Albina Tummolo at Children Hospital Giovanni XXIII, Italy.

Dr. Albina Tummolo is an accomplished pediatrician specializing in metabolic and genetic disorders. With over two decades of clinical and academic experience, she has built a significant profile in managing and researching rare pediatric diseases. Based at the Policlinico of Bari, she combines patient care with academic research, national coordination roles, and continuous engagement with international advisory boards. Dr. Tummolo is also an active educator, teaching at several Italian universities and training healthcare professionals in hereditary metabolic diseases. Her work has shaped protocols and policies for improved pediatric metabolic care in Italy.

Publication Profile

Orcid

Education

Dr. Albina Tummolo earned her Degree in Medicine and Surgery from the University of Foggia in 2002 and completed her Specialization in Pediatrics (General and Specialist) at the University of Bari in 2007. She holds multiple postgraduate certifications in specialized pediatrics, infectivity, rheumatology, and rare diseases from the University of Bari and the University of Florence. She furthered her academic credentials with an MSc in Clinical Pediatrics from University College London in 2008 and a PhD in Pediatric Sciences from the University of Bari in 2011. In 2023, she completed an MSc in Epidemiology and Biostatistics at Università Cattolica di Roma.

Experience

Dr. Tummolo currently serves as a Senior Pediatrician at the Ospedale Pediatrico “Giovanni XXIII” in Bari, within the Unit of Metabolic and Genetic Diseases, a role she has held since 2015. She has also worked as a senior pediatrician at the Azienda Ospedaliera di Padova and Presidio Ospedaliero “Perrino” dell’ASL di Brindisi. She is a registered physician with the Order of Physicians and Surgeons of Bari (License No. 5742, since September 18, 2003).

Dr. Tummolo has extensive experience leading and participating in clinical trials and observational studies focused on inborn errors of metabolism, lysosomal storage disorders, and rare genetic conditions, often acting as Principal Investigator or Scientific Coordinator. She serves as a member and secretary of national expert committees and advisory boards and contributes to shaping diagnostic and therapeutic strategies for metabolic disorders in Italy and Europe.

Research Focus

Inborn errors of metabolism and rare genetic diseases
Lysosomal storage disorders (including LAL-D, Gaucher disease, and alpha-mannosidosis)
Phenylketonuria (PKU) and organic acidurias
Neonatal screening programs
Epidemiology and real-world evidence in pediatric metabolic disorders
Nutritional and enzyme replacement therapies in pediatric populations

Author Metrics & Scientific Contributions

Principal Investigator in multiple national and international clinical trials
Scientific Member of the Telethon Undiagnosed Diseases Program (TUDP) and E-HOD
Coordinator/Advisor for over 30 expert boards and working groups, including SIMMESN
Co-author of educational and clinical monographs, including:
- “Inherited Metabolic Disorders Neonatal Screening” (2014)
- Educational booklets on MSUD, TYR, HCU, MMA/PA, GA, IVA, and PKU (2020–2022)
- Springer Healthcare Monography (2025) on velmanase alfa treatment in alpha-mannosidosis

She has contributed substantially to national consensus statements, educational masterclasses, and international forums on metabolic disease management.

Publication Top Notes

1. Exploring Partners, Parenting and Pregnancy Thinking in Late Adolescents and Young Adults with Inherited Metabolic Disorders

📅 Pediatric Reports, May 2025
🔗 DOI: 10.3390/pediatric17030056
👩‍🔬 Contributors: Albina Tummolo, Giulia Paterno, Rosa Carella, Livio Melpignano, Donatella De Giovanni
Focus: Examines reproductive health perspectives in adolescents and young adults affected by inherited metabolic disorders.

2. Growth Parameters and Prevalence of Obesity in PKU Patients and Peers: Is This the Right Comparison?

📅 Pediatric Reports, October 2024
🔗 DOI: 10.3390/pediatric16040076
👩‍🔬 Contributors: Giulia Paterno, Vito Di Tullio, Rosa Carella, Giada De Ruvo, Fabrizio Furioso, Aleksandra Skublewska-D’Elia, Donatella De Giovanni, Albina Tummolo
Focus: Investigates obesity prevalence among patients with phenylketonuria (PKU) versus healthy peers.

3. Intake Modalities of Amino Acid Supplements: A Real-World Data Collection from Phenylketonuria Patients

📅 Nutrients, February 2024
🔗 DOI: 10.3390/nu16050669
👩‍🔬 Contributors: Albina Tummolo, Rossella Carella, Pasquale Carone, Giulia Paterno, Donatella De Giovanni
Focus: Real-world insights into how PKU patients consume amino acid supplements.

4. CHAMP1-related Disorders: Pathomechanisms Triggered by Different Genomic Alterations Define Distinct Nosological Categories

📅 European Journal of Human Genetics, 2023
🔗 DOI: 10.1038/S41431-023-01305-Z
🔍 WOSUID: WOS:000939855800002
👩‍🔬 Contributors: Amenta S., Marangi G., Orteschi D., Frangella S., Gurrieri F., Paccagnella E., Scala M., Romano F., Capra V., Nigro V., et al.
Focus: Differentiates clinical categories of CHAMP1-related disorders based on genomic mechanisms.

5. Long-term Safety and Efficacy of Velmanase Alfa Treatment in Children Under 6 Years of Age with Alpha-Mannosidosis: A Phase 2, Open Label, Multicenter Study

📅 Journal of Inherited Metabolic Disease, 2023
🔗 DOI: 10.1002/JIMD.12602
🔍 WOSUID: WOS:000948401000001
👩‍🔬 Contributors: Guffon N., Konstantopoulou V., Hennermann J.B., Muschol N., Bruno I., Tummolo A., Ceravolo F., Zardi G., Ballabeni A., Lund A.
Focus: Evaluates velmanase alfa’s therapeutic profile in pediatric alpha-mannosidosis patients.

Conclusion

Dr. Albina Tummolo exemplifies the core values of the Best Researcher Award in Medicine and Health Sciences through her compassion-driven pediatric care, trailblazing research, and influence on national health systems. Her unique blend of clinical depth, academic rigor, and policy impact makes her an ideal candidate for this recognition.

She not only advances medical science but also improves the lives of children with rare diseases—one diagnosis, one protocol, and one family at a time.

Lina Vieira | Medicine and Health Sciences | Research Hypothesis Excellence Award

Posted on 30/04/202530/04/2025 by ScienceFather

Lina Vieira | Medicine and Health Sciences | Research Hypothesis Excellence Award

Prof Lina Vieira, ESTeSL/IPL, Portugal

Prof. Lina Vieira is a distinguished biomedical researcher and educator with a PhD in Biomedical Engineering and Biophysics from the University of Lisbon 🎓, awarded with Distinction and Honors 🏅. Her work primarily advances nuclear medicine, with a special focus on myocardial perfusion scintigraphy and SPECT imaging 🧠❤️. She holds a professorial position at the Lisbon School of Health Technology, actively contributing to both teaching and scientific innovation 📚🔬. Prof. Vieira has led several EU-funded projects, including PIANOFORTE, focusing on safe, optimized radiology for vulnerable populations 🤰📡. Her research blends technology, biophysics, and human-centered approaches like anxiety reduction and music therapy in imaging 🧘‍♀️🎵. An award-winning author and supervisor, she has trained numerous graduate students and remains a leading voice in radiological safety and optimization ⚛️. Her scientific rigor, innovation, and societal impact make her an ideal candidate for the Research Hypothesis Excellence Award 🏆🔍.

Publication Profile

Orcid

Education

Prof. Lina Vieira earned her PhD in Biomedical Engineering and Biophysics from the University of Lisbon in 2011 with Distinction and Honors 🎓🌟. Her thesis focused on optimizing myocardial perfusion studies using ECG-gated nuclear medicine imaging ❤️🧠. She also holds a Postgraduate Degree in Medical Physics and Biomedical Engineering (2005) and a Bachelor’s in Nuclear Medicine (2000) from the Lisbon School of Health Technology ⚛️📘. As part of her academic growth, she qualified through rigorous public examinations to become a Coordinating Professor in Nuclear Medicine within the Radiation Sciences and Biosignal Technologies Department at ESTeSL 👩‍🏫🧪. Her scholarly training is grounded in biophysics, imaging technology, and healthcare applications, forming a strong foundation for her future academic, research, and leadership achievements 🔬💡.

Experience

Prof. Vieira serves as a Coordinating Professor at the Lisbon School of Health Technology, leading Nuclear Medicine teaching and research initiatives 👩‍🏫🧠. She has been an integrated member of the Health & Technology Research Center since 2019, previously with the Institute of Biophysics and Biomedical Engineering at the University of Lisbon 🧬📊. Her work spans across modeling, signal processing, and human-centered diagnostic imaging, including participation in CIMOSM and GI-MOSM research centers 🧠⚙️. Notably, she coordinates the EU-funded PIANOFORTE project on safe radiology for pregnant patients 🤰📡, and leads innovative research on anxiety and music’s impact on image quality 🎵😌. Prof. Vieira is a mentor to many MSc students and has supervised several dissertations on SPECT imaging, Parkinson’s diagnostics, and PET education 📚📝. Her cross-disciplinary expertise makes her a leader in merging clinical practice with scientific excellence 🏥🔍.

Awards and Honors

Prof. Vieira has received multiple prestigious awards honoring her innovative research in nuclear medicine and imaging technology 🏅📡. She earned the Best Scientific Article Award from Saúde & Tecnologia in 2018, 2017, and 2015 for studies on technologist exposure, myocardial perfusion, and PET/CT in melanoma surveillance 🎖️📘. Her paper, “Value of a Lower Limb Immobilization Device for Optimization of SPECT/CT Image Fusion,” was named one of the Top 3 Papers by JNMT in 2015 and recognized at the 2016 Annual SNMMI Congress in San Diego 🇺🇸✨. These accolades reflect her commitment to high-impact, hypothesis-driven research that enhances clinical outcomes and patient safety 🧠❤️. With consistent recognition over the years, Prof. Vieira continues to lead innovations in nuclear medicine, both theoretically and practically 🔬📈.

Research Focus

Prof. Vieira’s research centers on optimizing nuclear medicine imaging, particularly myocardial perfusion scintigraphy (MPS), SPECT acquisition techniques, and patient-centered innovations in diagnostic imaging ❤️📸. She investigates the impact of psychophysiological variables, such as anxiety, on image quality and explores non-pharmacological interventions like music therapy to improve patient outcomes 🎶🧘‍♂️. A strong advocate for radiological safety, she spearheads projects like PIANOFORTE, which targets personalized radiology for pregnant patients 🤰⚛️. She also delves into educational methodologies, evaluating the effect of videos and social media in communicating ionizing radiation risks effectively 📲🧠. Her interdisciplinary focus combines engineering, patient psychology, radiological science, and public communication—making her work vital for improving both technical precision and patient experience in medical imaging 💡🩺. Her hypothesis-driven approach is rooted in measurable impacts, clinical relevance, and ethical responsibility 🔍📐.

Publication Top Notes

📄 Myocardial Perfusion Scintigraphy: Impact of Anxiety on Image Quality (JPM, 2025 – submitted)
📄 Potential Benefits of Social Media in Educating Healthcare Professionals and Students on Medical Imaging with Ionizing Radiation (Radiography Journal, 2025)
📄 Effects of a Music-Based Intervention on Psychophysiological Outcomes of Patients Undergoing Imaging Procedures: A Systematic Review (Radiography Journal, 2024)
📄 Effectiveness of Educational Videos on Patient’s Preparation for Diagnostic Procedures: Systematic Review and Meta-Analysis (Preventive Medicine Reports, 2022)

YONGFANG HU | Medicine and Health Sciences | Best Researcher Award

Posted on 23/04/202523/04/2025 by ScienceFather

YONGFANG HU | Medicine and Health Sciences | Best Researcher Award

Assoc. Prof. Dr YONGFANG HU, Beijing Tsinghua Changgung Hospital, China

Assoc. Prof. Dr. Yongfang Hu is a distinguished clinical pharmacist and academic with over three decades of impactful service in pharmacy and pharmacology. 📚🧬 She earned her degrees from Lanzhou University and Central South University, focusing on pharmacology and clinical pharmacology. 💊 She has held prominent roles at leading institutions such as Lanzhou University, Peking University Third Hospital, and Tsinghua Changgung Hospital. 🌟 Her pioneering research covers pharmacogenomics, organ transplant pharmacotherapy, and elderly care medication. 🧠💉 A highly respected scholar, she has authored influential publications and led studies on multidrug-resistant infections and personalized medicine. 📈🧫 Dr. Hu’s commitment to advancing safe, effective drug therapies makes her a standout candidate for the Best Researcher Award. 🌐🥇

Publication Profile

Orcid

Education

Dr. Yongfang Hu’s academic journey began with a Bachelor’s Degree in Pharmacy from the School of Pharmacy, Lanzhou University (1988). 🎓💊 She further pursued a Master’s Degree in Pharmacology from the same institution in 2000, deepening her understanding of drug mechanisms and therapeutic strategies. 🔬📘 To solidify her expertise in clinical applications, she earned a Doctorate in Clinical Pharmacology from the Institute of Clinical Pharmacology, Central South University (2005). 🧬📖 Her academic training spans fundamental pharmacy, experimental pharmacology, and patient-centered pharmacotherapy, laying a strong foundation for her research in genomics, drug therapy, and personalized medicine. 🧠🧪 Each milestone in her educational path reflects her lifelong dedication to pharmacological sciences and clinical excellence. 🏅📚

Experience

From 1988 to 2002, Dr. Hu served as a Deputy Chief Pharmacist and Associate Professor at the Second Affiliated Hospital of Lanzhou University. 🏥📘 She later joined Peking University Third Hospital (2005–2014) as a Chief Pharmacist and Associate Professor, advancing clinical pharmacy services and academic programs. 🧪📈 Between 2014 and 2015, she led the Pharmacy Department at Tsinghua Changgung Hospital, and since 2015, she continues there as a Chief Pharmacist and Associate Professor of Clinical Pharmacy. 🧬🏥 Her clinical and academic leadership across top Chinese institutions showcases her expertise in implementing advanced pharmaceutical care and mentoring future pharmacists. 💡🎓

Awards and Honors

Dr. Hu has received multiple recognitions for her excellence in pharmacy and research. 🏆 In her tenure, she has been honored with Institutional Excellence Awards for Clinical Pharmacy Innovation and Outstanding Research Contributions at Peking University Third Hospital and Tsinghua Changgung Hospital. 🎖️ She has been invited to serve on editorial boards and academic review committees, reflecting her standing in the scientific community. 📚👩‍⚕️ Her extensive work on drug genomics and personalized medicine has earned her accolades at national pharmacology conferences. 🧬🌟 These honors signify her continuous impact on both patient care and the broader medical research landscape. 🧠🏅

Research Focus

Dr. Hu’s research primarily focuses on the genomics of organ transplantation drugs and pharmacogenomics of thromboembolic diseases. 🧬🫀 She explores how genetic variations influence drug responses, aiming to tailor therapies for optimal patient outcomes. 🧠💊 She also delves into drug therapies for infectious diseases, including strategies to combat multidrug-resistant organisms, particularly in transplant patients. 🧫🛡️ Her work extends to cardiovascular pharmacotherapy and medication optimization in the elderly population, tackling polypharmacy and age-related metabolic changes. 👵❤️ Through clinical studies and predictive modeling, Dr. Hu drives personalized medicine in real-world settings. 📊🔍 Her interdisciplinary approach bridges pharmacology, genomics, and patient care. 🌐🔗

Publication Top Notes

Epidemiology and Risk Prediction Model of Multidrug-Resistant Organism Infections After Liver Transplant Recipients: A Single-Center Cohort Study 🧫🧬

Tawanda Chivese | Medicine and Health Sciences | Best Researcher Award

Posted on 22/04/202522/04/2025 by ScienceFather

Tawanda Chivese | Medicine and Health Sciences | Best Researcher Award

Assist. Prof. Dr Tawanda Chivese, University of Washington Tacoma, United States

Assist. Prof. Dr. Tawanda Chivese is an accomplished epidemiologist specializing in clinical epidemiology. With a Ph.D. in Medicine from the University of Cape Town, and an MSc (cum laude) in Clinical Epidemiology from Stellenbosch University, Dr. Chivese has a strong foundation in advanced epidemiological methods, biostatistics, and global health. He is currently an Assistant Professor of Epidemiology at the University of Washington Tacoma, and an Extraordinary Senior Lecturer at Stellenbosch University. Over his career, Dr. Chivese has led impactful international research on diabetes, gestational diabetes, cardiometabolic diseases, and mental health outcomes. His work has been published in high-impact peer-reviewed journals, and he actively contributes as a journal reviewer and editorial board member. Dr. Chivese’s commitment to academic excellence, mentorship, and research collaboration marks him as a distinguished researcher with significant contributions to global public health.

Publication Profile

Orcid

Education

Dr. Tawanda Chivese holds a Ph.D. in Medicine (2021) from the University of Cape Town, where he investigated the long-term effects of hyperglycemia in pregnancy on offspring obesity and cardiovascular risk. He earned his MSc Clinical Epidemiology (cum laude, 2014) from Stellenbosch University, completing advanced coursework in epidemiology, biostatistics, and systematic reviews. His Master’s research focused on cigarette smoking and Crohn’s Disease phenotypes. Earlier, he completed a Bachelor of Science (Honours) in Nursing Science (2006) from the University of Zimbabwe, developing a strong clinical foundation. He has supplemented his formal education with specialized training in systematic reviews, digital skills, blended learning, biomedical ethics, and diagnostic test accuracy through global institutions like the University of Birmingham and the University of Oxford. Dr. Chivese’s comprehensive education underpins his expertise in clinical epidemiology and global health research.

Experience

Dr. Chivese is currently an Assistant Professor (tenure-track) at the University of Washington Tacoma (2024-present), leading epidemiology and public health teaching, collaborative research on gestational diabetes, and supervising student research. Previously, he served as Assistant Professor at Qatar University (2019-2024), where he coordinated key courses, redesigned epidemiology curricula, and mentored over 100 student researchers, many winning top awards. He fostered collaborations with the Qatar Ministry of Public Health and Qatar Biobank. Concurrently, Dr. Chivese has held honorary positions at Stellenbosch University and the South African Medical Research Council since 2016. His experience combines academic leadership, innovative teaching, curriculum development, large-scale collaborative research, and scholarly publication. His global impact is evidenced by partnerships across Africa, the Middle East, and the U.S., positioning him as a leading figure in global clinical epidemiology.

Awards and Honors

Dr. Tawanda Chivese’s dedication to excellence has earned him multiple accolades. He received consistent teaching excellence awards during his tenure at Qatar University and awards for supervising the best undergraduate research projects. His leadership contributions to the Public Health Association of South Africa, serving on the executive board and as Vice Chairperson for a special interest group, underline his influence in public health leadership. His scholarly work has been recognized with prestigious grants, including funding from Qatar Foundation, Welcome Trust, and SAMRC/Newton Fund. In addition, he has been selected as an editorial board member for BMC Public Health and frequently reviews for top-tier journals like The Lancet and PLOS Medicine. These honors reflect his outstanding achievements in research, teaching, mentorship, and service to the academic and public health communities.

Research Focus

Dr. Chivese’s research primarily focuses on the intersection of metabolic and mental health diseases, particularly diabetes, cardiovascular risks, and cognitive outcomes post-gestational diabetes. He specializes in clinical epidemiology, meta-analysis, and diagnostic accuracy studies. His recent projects include investigating the developmental origins of autism spectrum disorders, the role of poor glycemic control in cognitive dysfunction, and refining meta-analysis methods for improved evidence synthesis. He also leads collaborative studies on lifestyle interventions to prevent cardiometabolic diseases in high-risk populations. His work aims to uncover critical determinants of chronic disease progression and provide actionable public health interventions. Dr. Chivese’s research approach is interdisciplinary, combining clinical insight, advanced statistical methods, and global collaboration to address complex health challenges in both low- and high-income settings.

Publication Top Notes

Prevalence of unintended pregnancy in the MENA region: a systematic review and meta-analysis

Infoveillance of COVID-19 Infections in Dentistry Using Platform X: Descriptive Study

Comparative Efficacy of Subcutaneous Versus Intravenous Interleukin 12/23 Inhibitors for the Remission of Moderate to Severe Crohn’s Disease: A Systematic Review and Meta-Analysis

Cross-cultural adaptation: South African Gestational Diabetes Mellitus Knowledge Questionnaire

Prevalence and factors associated with falls in older adults in a Middle Eastern population: a retrospective cross-sectional study

Estimates of the prevalence of male circumcision in sub-Saharan Africa from 2010–2023—A systematic review and meta-analysis

Integrated health system intervention aimed at reducing type 2 diabetes risk in women after gestational diabetes in South Africa (IINDIAGO): a randomised controlled trial protocol

Yong Ahn | Medicine and Health Sciences | Best Researcher Award

Posted on 22/04/202522/04/2025 by ScienceFather

Yong Ahn | Medicine and Health Sciences | Best Researcher Award

Prof. Dr Yong Ahn, Kyung Hee University Hospital, Kyung Hee University College of Medicine at Gangdong, Kyung Hee University College of Medicine, South Korea

Prof. Dr. Yong Ahn is a globally recognized leader in minimally invasive spine surgery. Having earned his MD and PhD from Seoul National University School of Medicine, Dr. Ahn has devoted his career to advancing surgical techniques that minimize patient recovery time and improve outcomes. Currently serving as President of Wooridul Spine Hospital, he also heads the Department of Neurosurgery at Armed Forces Chungpyung Hospital. Dr. Ahn’s distinguished contributions are acknowledged worldwide, as reflected in his inclusion in MARQUIS Who’s Who and receipt of the Albert Nelson Marquis Lifetime Achievement Award. He holds pivotal roles in several spine surgery societies, chairs editorial boards for prestigious journals, and actively shapes the field through extensive research and publication. His dedication and innovations make him an exemplary candidate for the Best Researcher Award.

Publication Profile

Orcid

Education

Prof. Dr. Yong Ahn completed both his MD and PhD at the prestigious Seoul National University School of Medicine in Korea. Beyond his medical degrees, he expanded his expertise internationally, becoming a Fellow of the American Board of Minimally Invasive Spinal Surgery and the Royal College of Physicians and Surgeons. His educational background is marked by a combination of rigorous academic training and a forward-looking vision for medical innovation. Dr. Ahn’s academic pursuits laid a strong foundation for his pioneering work in minimally invasive techniques and spinal endoscopy, fields in which he would later become a leading authority. His commitment to lifelong learning and professional development exemplifies the values necessary for outstanding contributions to medical science.

Experience

Dr. Yong Ahn has had an illustrious career, marked by leadership and innovation in spine surgery. He currently serves as the President of Wooridul Spine Hospital and as Head of Neurosurgery at Armed Forces Chungpyung Hospital. Dr. Ahn also plays critical roles in academic societies, including being Chairperson of the Korean Endoscopic Spine Surgery Society and Scientific Manager of the Korean Minimally Invasive Spine Surgery Society. His expertise extends to national policy, where he serves on the Inter-Ministerial Evaluation Committee for national R&D projects. As Editor-in-Chief of JMISST-Video and an editorial board member of European Spine Journal, Biomed Research International, and PLOS One, he influences scientific communication globally. His experience is distinguished by a balance between surgical excellence, academic leadership, and contributions to national and international healthcare systems.

Awards and Honors

Prof. Dr. Yong Ahn’s outstanding achievements have been recognized through numerous prestigious awards. He received the Gachon University President’s Special Award for Research Excellence in 2020, honoring his significant research contributions. In 2018, he was awarded the Albert Nelson Marquis Lifetime Achievement Award, further confirming his global impact. Dr. Ahn’s inclusion in the MARQUIS Who’s Who reflects his longstanding influence and excellence in the field of spine surgery. His leadership positions within various professional societies and editorial roles also signify peer recognition of his professional authority and contributions. Each award not only celebrates his past accomplishments but also highlights his continuing commitment to advancing medical science and patient care.

Research Focus

Dr. Yong Ahn’s research focuses primarily on minimally invasive spine surgery and endoscopic procedures. He is a pioneer in developing techniques that allow complex spinal conditions to be treated with reduced surgical trauma, faster recovery, and improved patient outcomes. His studies address critical topics such as the learning curve associated with minimally invasive techniques, surgical complications like dural tears, and innovations in endoscopic decompression procedures. Dr. Ahn’s research bridges clinical practice and technological advancement, making significant strides in the refinement of surgical methods. As an editor and author of core textbooks in his field, he also contributes to education and knowledge dissemination. His commitment to evidence-based practice ensures that his research directly benefits both the scientific community and patients worldwide.

Publication Top Notes

Magnetic Resonance Imaging Predictors of Surgical Difficulty in Transforaminal Endoscopic Lumbar Discectomy for Far-Lateral Disc Herniation Under Local Anesthesia

A Commentary on “Full-Endoscopic Resection of a Lumbar Intradural Tumor (Schwannoma): Video Case Report and Description of the Surgical Technique”

Transforaminal Endoscopic Lumbar Foraminotomy for Iatrogenic Foraminal Stenosis Following Vertebroplasty

Access Pain During Transforaminal Endoscopic Lumbar Discectomy for Foraminal or Extraforaminal Disc Herniation

Access Pain during Transforaminal Endoscopic Lumbar Discec-Tomy for Foraminal or Extraforaminal Disc Herniation

Learning Curve for Endoscopic Transsphenoidal Surgery: A Systematic Review and Meta-Analysis

Bruno Songel Sanchis | Medicine and Health Sciences | Best Review Paper Award

Posted on 21/04/202521/04/2025 by ScienceFather

Bruno Songel Sanchis | Medicine and Health Sciences | Best Review Paper Award

Mr Bruno Songel Sanchis, Hospital clínico San Carlos, Spain

Mr. Bruno Songel Sanchis 🎻👓 is a versatile professional with dual expertise in music and vision sciences. Holding a Master’s in Optometry and Vision Sciences from the Complutense University of Madrid 🎓, and a degree in Optics and Optometry from the University of Valencia, he seamlessly combines clinical acumen with research innovation. His extensive clinical experience spans Hospital Clínico San Carlos and Fundación Salud Visual, focusing on cutting-edge myopia control, glaucoma diagnostics, and AI integration in ophthalmology 🤖🧠. Beyond clinics, Bruno’s passion for community service is evident through his impactful volunteer roles and outreach projects 🫶. A talented cellist 🎶 and a committed scientist, he bridges the gap between art and science with grace and dedication. His systematic review on ocular manifestations in IBD showcases his research depth 📄📊. A creative thinker and empathetic clinician, Bruno is a promising contender for the Best Review Paper Award 🥇🧬.

Publication Profile

Orcid

Education

Bruno Songel Sanchis has a rich and interdisciplinary educational background 🎓✨. He earned his Professional Degree in Music (Violoncello) from the Professional Music Conservatory of Valencia 🎻, showcasing his artistic talents. He later pursued a Scientific Baccalaureate at San José de Calasanz High School 🧪📘. Bruno’s scientific journey led him to the University of Valencia, where he obtained his Degree in Optics and Optometry 👁️📐. Committed to advancing vision care, he continued with a Master’s Degree in Optometry and Vision Sciences at the prestigious Complutense University of Madrid 👓🔬. He’s currently engaged in Project Efficiency Boost (2025–present), enhancing clinical productivity through AI and innovation 🚀🤖. His academic versatility reflects both analytical rigor and creativity, a rare blend that empowers his impactful work in clinical practice and scientific research 🧠📚.

Experience

Bruno has extensive hands-on experience in both clinical and research settings 🏥🔬. He served as a Clinical Optometrist at Hospital Clínico San Carlos (Madrid), rotating across subspecialties like myopia, retina, glaucoma, and cataracts 👁️💉. He contributed to pivotal research on myopia control with Atropine and later as a Clinical Research Technician at IdISSC, focused on the ‘LYDIA project’ developing AI diagnostic tools 🤖📊. His role as a Product Specialist marked a major milestone—implementing Europe’s first AI-powered ophthalmic imaging system at La Paz Hospital 🏥✨. Earlier, he worked at Óptica Universitaria and Alain Afflelou, gaining practical skills in optometry, sales, and customer care 🛠️🛍️. Bruno also holds a current role at Fundación Salud Visual (Funsavi), continuing his clinical contributions while mentoring others. These experiences shape him into a well-rounded professional with deep clinical knowledge, technical skills, and patient-centered care focus 👓🫶.

Awards and Honors

Bruno Songel Sanchis has garnered multiple honors for both creativity and scientific excellence 🏆📚. He won 1st prize in the UV Creative Outreach Project (2021) for innovative public science engagement 🎨💡. At the UVemprén Startup – Crea Awards, he secured 3rd position for his entrepreneurial vision in healthcare 🔬🚀. His musical talents earned him an Honorable Mention Diploma at an International Music Seminar, reflecting his multifaceted abilities 🎶🏅. He was also a Finalist in the MOTIVEM UV Awards, acknowledging his academic initiative and leadership 📘👏. As a Rapporteur at the SIYO 2022 Congress for Young Optometrists, he showcased his ability to bridge science and communication 🗣️📊. His certifications from the London School of Hygiene and Tropical Medicine in public health ophthalmology further validate his global competence in preventing blindness and tackling ocular diseases on an international level 🌍👁️.

Research Focus

Bruno Songel Sanchis’s research focuses on clinical optometry, ocular disease prevention, and artificial intelligence applications in ophthalmology 🧠👁️🤖. His major interests include myopia control, particularly using Atropine-based treatments, and early detection of age-related macular degeneration and glaucoma through AI-powered diagnostic systems 🧬📈. In collaboration with top-tier hospitals and research institutions, Bruno played a pivotal role in developing multi-diagnostic tools and conducting clinical trials on visual pathologies. His review on ocular extraintestinal manifestations in inflammatory bowel disease (IBD) offers critical insights into interdisciplinary patient care 📄🩺. A blend of practical clinical work and technical innovation defines his approach, with the goal of improving accessibility and effectiveness of vision care globally 🌐✨. His ongoing contributions to AI integration, coupled with community eye health initiatives, make him a forward-thinking optometrist and researcher committed to impactful, data-driven healthcare advancements 🩻📊.

Publication Top Notes

Analysis of the Incidence of Ocular Extraintestinal Manifestations in Inflammatory Bowel Disease Patients: A Systematic Review (2024)

Karen Kengne Kamga | Genetics and Genomics | Best Researcher Award

Posted on 21/04/202521/04/2025 by ScienceFather

Karen Kengne Kamga | Genetics and Genomics | Best Researcher Award

Dr Karen Kengne Kamga, Limbe Regional Hospital, south west, Cameroon, Cameroon

Dr. Karen Kengne Kamga is a dynamic physician-scientist from Cameroon, blending clinical expertise with advanced research in human and medical genetics. With an M.D. from the University of Yaoundé I and a Ph.D. in Genetic Counselling from the University of Cape Town, she has become a leading figure in genomic medicine across Africa. She currently serves as a postdoctoral researcher in Human Genetics, Head of Medical Genetics at Limbe Regional Hospital, and Associate Lecturer at the University of Yaoundé I. Passionate about bridging clinical gaps in genetic services in Africa, she’s contributed significantly to fragile X syndrome understanding and healthcare system integration of genetic counselling. Dr. Kamga is a strong advocate for capacity building, precision public health, and equitable genomic research.

Publication Profile

Orcid

Education

Dr. Kamga began her academic journey at GBHS Bafoussam, completing her GCE Ordinary and Advanced Levels. She earned her MD in General Medicine from the University of Yaoundé I in 2013. Driven by a passion for genetics, she pursued a Ph.D. in Genetic Counselling at the University of Cape Town, which she completed in December 2021. To expand her administrative and clinical leadership, she enrolled in an MBA in Health Management at UNICAF University, completed in 2023. She is also pursuing a Master’s in Clinical Genetics at Tech Global University, Andorra (2023–2024). In parallel, she is a postdoctoral fellow in Human Genetics at the University of Cape Town since 2021. Her multi-disciplinary training spans medicine, genetics, health management, epidemiology, and bioinformatics, equipping her to lead innovation in genomic healthcare delivery in low-resource settings.

Experience

Dr. Kamga’s career began as a physician at “Cabinet de soin St Dominique” (2013–2014), followed by multiple leadership roles at District Hospital Limbe from 2014 to 2023, including Head of Pediatrics, Gynecology/Obstetrics, Surgical Unit, ANC & EPI, and Laboratory Coordinator. In 2023, she became Head of Medical Genetics at the Limbe Regional Hospital. Simultaneously, since 2024, she is an Associate Lecturer at the University of Yaoundé I. Her experience reflects a strong commitment to integrating genetic services within mainstream healthcare and public health teaching. Her roles have combined clinical excellence, mentorship, and system-level leadership, all contributing to a national vision for personalized medicine and public health genetics.

Awards and Honors

Dr. Kamga’s research excellence has been widely recognized through prestigious international honors. She received the 2024 Resource-Limited Country Travel Award and the 2021 & 2020 Developing Country Virtual Meeting Awards from the American Society of Human Genetics (ASHG). In 2019, she earned the ASHG Developing Country Travel Award. These honors reflect her impactful presence in the global genetics research community. She is also a respected member of several professional societies: ASHG (since 2020), African Society of Human Genetics (since 2017), and the Cameroon Society of Human Genetics (since 2015). Her accolades underscore a consistent dedication to research, equity, and capacity building in genetic medicine in Africa.

Research Focus

Dr. Kamga’s research focuses on bridging the gap between advanced genetic knowledge and its clinical implementation in Africa. Her Ph.D. investigated cultural perceptions and explanatory models of Fragile X Syndrome in rural Cameroon, highlighting the need for community-sensitive genetic counselling. As a postdoctoral fellow, she explores the integration of human genetics into public health, emphasizing equitable access to genomic services. She led a scoping review identifying strategic pathways to strengthen genetic healthcare in Africa. Her work spans genomic ethics, bioinformatics, genetic education, and precision public health, consistently aiming to enhance genetic literacy and healthcare systems in resource-limited settings. She is deeply involved in collaborative African genomics initiatives like H3Africa, and committed to mentoring emerging scientists.

Publication Top Notes

Advancing Genetic Services in African Healthcare: Challenges, Opportunities, and Strategic Insights from a Scoping Review

Navigating the Genetic Frontier for the Integration of Genetic Services into African Healthcare Systems: A scoping review

Perceptions and preferences for genetic testing for sickle cell disease or trait: a qualitative study in Cameroon, Ghana and Tanzania

Caught between pity, explicit bias, and discrimination: a qualitative study on the impact of stigma on the quality of life of persons living with sickle cell disease in three African countries

Explanatory models for the cause of Fragile X Syndrome in rural Cameroon

Knowledge and Challenges Associated With Hearing Impairment in Affected Individuals From Cameroon (Sub-Saharan Africa)

Negotiating political power and stigma around fragile X Syndrome in a rural village in Cameroon: A tale of a royal family and a community

Yu Pan | Medicine and Health Sciences | Young Scientist Award

Posted on 16/04/202516/04/2025 by ScienceFather

Yu Pan | Medicine and Health Sciences | Young Scientist Award

Dr Yu Pan, Fujian Medical University Union Hospital, China

Dr. Yu Pan is a pioneering medical scientist and attending physician at the Department of General Surgery, Fujian Medical University Union Hospital, China. His groundbreaking research bridges immunotherapy and pancreatic cancer treatment, focusing on mechanisms shaping the tumor microenvironment and translating them into clinical applications. As the principal investigator of multiple prestigious grants, Dr. Pan leads a laboratory exploring mRNA vaccine development and immune regulation in pancreatic malignancies. With over a dozen high-impact publications, including in Nature Nanotechnology and JITC, his work is rapidly transforming the therapeutic landscape. An active mentor and educator, he has guided eight Master’s students, several of whom now pursue PhDs or hold clinical positions at top hospitals. Recognized for academic excellence and innovation, Dr. Pan exemplifies the qualities of a future leader in oncology and immunology. His contributions reflect a deep commitment to both science and society.

Publication Profile

Orcid

Education

Dr. Yu Pan is a dedicated medical professional with a strong academic background in Medical Sciences 🧠🔬. He began he journey in medicine at Anhui Medical University, China, where he earned he Bachelor’s degree between 2008 and 2013 🎓🇨🇳. He passion for advancing healthcare led he to pursue further studies at Fujian Medical University. From 2014 to 2017, he completed he Master’s degree in Medical Sciences, specializing in General Surgery 🏥🩺. Demonstrating exceptional commitment to surgical research and clinical excellence, Dr. Pan continued at the same university to obtain her Ph.D. in Medical Sciences from 2017 to 2020 🎓🔍. During her academic career, she gained extensive experience in surgical techniques, research methodologies, and patient care, contributing significantly to the field of general surgery 📚. He educational path reflects a continuous pursuit of knowledge and skill development, underscoring he role as a dedicated surgeon and researcher committed to medical innovation and patient well-being ❤️‍🩹.

Experience

Dr. Yu Pan is a dedicated surgical professional with extensive experience in clinical practice, teaching, and mentorship. From 2020 to 2022, Dr. Pan completed a surgical residency at the Department of Surgery, Fujian Medical University Union Hospital 🏥. Since 2022, he has served as a Staff Attending Physician in the Department of General Surgery 👨‍⚕️. Alongside his clinical duties, Dr. Pan has been actively involved in teaching as an Instructor for Clinical Skills Training Classes (2022–2024) at Fujian Medical University 🎓. He has also served as a thesis advisor for Master’s students since 2021, mentoring eight students in total. Five have graduated, with three pursuing PhDs and two now practicing at top institutions, including Jinhua Hospital and Fudan University Shanghai Cancer Center 🎯. His mentees have published in prestigious journals such as JITC, Functional Integrated Genomics, Frontiers in Pharmacology, and Cell Death & Disease 📚🔬, reflecting Dr. Pan’s strong academic impact.

Awards and Honors

Dr. Yu Pan is a highly accomplished medical researcher recognized for his consistent contributions to science and healthcare advancement 🧬🩺. He currently leads the 2025 Overseas Study Program for Young and Middle-Aged Medical Talents in Fujian Province 🌏✨. In 2023, he was selected for the Excellent Young Scholars Cultivation Project by Fujian Medical University Union Hospital (No. 2022XH025) 🧑‍🔬🏅. His expertise earned national recognition through the prestigious 2021 National Natural Science Foundation of China grant (No. 82103310) 🇨🇳🔍. That same year, he secured funding from the Natural Science Foundation of Fujian Province (No. 2021J01774) and played a pivotal role in the Joint Funds of the Scientific and Technological Innovation Program of Fujian Province (No. 2020Y9081) 💡🔬. Additionally, Dr. Pan led the 2020 Fujian Provincial Health Technology Project (No. 2020GGA029), further highlighting his dedication to medical research and innovation in the region.

Research Focus

Dr. Yu Pan’s research centers on pancreatic cancer and inflammatory-immune responses, with a strong emphasis on immune regulation, tumor microenvironment, and therapeutic targets 🧬🩸. His studies explore the role of Annexin A1, CD47-targeted therapies, and immune checkpoints in pancreatic disorders, especially pancreatic ductal adenocarcinoma (PDAC) and neuroendocrine neoplasms 🧫🧠. Through single-cell analysis, preclinical models, and clinical translation, Dr. Pan investigates how immune dynamics shape disease progression and treatment outcomes 🧪📊. His work contributes significantly to immunotherapy and precision medicine in gastrointestinal oncology, aiming to improve prognosis and treatment for patients with severe pancreatic conditions 💊🧠🧑‍⚕️.

Publication Top Notes

Annexin A1 regulates inflammatory-immune response and reduces pancreatic and extra- pancreatic injury during severe acute pancreatitis

Translating CD47-Targeted Therapy in Gastrointestinal Cancers: Insights from Preclinical to Clinical Studies

The prognostic and therapeutic value of the tumor microenvironment and immune checkpoints in pancreatic neuroendocrine neoplasms

Loss of Annexin A1 in macrophages restrains efferocytosis and remodels immune microenvironment in pancreatic cancer by activating the cGAS/STING pathway

High-dimensional single-cell analysis unveils distinct immune signatures of peripheral blood in patients with pancreatic ductal adenocarcinoma

Single-cell RNA sequencing revealed subclonal heterogeneity and gene signatures of gemcitabine sensitivity in pancreatic cancer

Prognostic value of preoperative enhanced computed tomography as a quantitative imaging biomarker in pancreatic cancer

Robert Nshimiyimana | Molecular Biology | Best Researcher Award

Posted on 28/03/202528/03/2025 by ScienceFather

Robert Nshimiyimana | Molecular Biology | Best Researcher Award

Dr Robert Nshimiyimana, Harvard Medical School, United States

Dr. Robert Nshimiyimana is a postdoctoral research fellow at Brigham and Women’s Hospital and Harvard Medical School, specializing in organic chemistry, biochemistry, and molecular biology. His research explores the identification of bioactive chemical signals, pathways, and cellular targets that enhance the innate resolution of inflammation. His contributions to inflammation resolution research have provided critical insights into therapeutic strategies for diseases driven by chronic inflammation. With expertise in mass spectrometry, nuclear magnetic resonance spectroscopy, and lipidomics, he plays a pivotal role in deciphering pro-resolving mediators in human biology. His work has resulted in multiple high-impact publications and recognition at prestigious international conferences. Passionate about mentoring and scientific outreach, Dr. Nshimiyimana is committed to advancing biomedical research and fostering collaborations to translate laboratory discoveries into clinical applications. His dedication to excellence and groundbreaking research make him a strong candidate for the Best Researcher Award.

Publication Profile

Google Scholar

Education

Dr. Robert Nshimiyimana holds a Ph.D. in Organic Chemistry from the University of Southern California (USC), where he conducted cutting-edge research in bioorganic synthesis and lipid mediators of inflammation. His doctoral work focused on developing synthetic pathways for bioactive molecules that regulate the inflammatory response. Prior to that, he earned a B.A. in Biochemistry and Molecular Biology from Hendrix College, where he gained foundational expertise in chemical biology and enzymology. As part of his academic journey, Dr. Nshimiyimana participated in an International Student Exchange Program (ISEP) at Ulster University, Northern Ireland, broadening his scientific perspective and fostering global collaborations. His multidisciplinary education in chemistry, molecular biology, and biochemistry has provided him with a unique skill set to tackle complex biomedical challenges. His academic excellence and research contributions have established him as a rising leader in inflammation resolution and lipidomics research.

Experience

Dr. Robert Nshimiyimana has held multiple prestigious research positions, including his current role as a postdoctoral research fellow at Brigham and Women’s Hospital and Harvard Medical School. Here, he investigates pro-resolving lipid mediators and their role in inflammation resolution. 📚 During his Ph.D. at USC, he served as a graduate research associate, focusing on the total synthesis of bioactive molecules and their impact on cellular signaling pathways. His research contributed to developing novel therapeutics targeting chronic inflammatory diseases. 👨‍🏫 Additionally, he has served as an instructor and teaching assistant for organic chemistry and biochemistry, mentoring students in advanced analytical techniques such as NMR, mass spectrometry, and chromatography. 💡 His expertise in chemical biology, lipidomics, and bioorganic chemistry has positioned him as a leading scientist in the study of inflammation and disease mechanisms, making him a prime candidate for the Best Researcher Award.

Awards and Honors

Dr. Robert Nshimiyimana has been recognized with numerous prestigious awards, highlighting his impactful contributions to biomedical research. ✨ He received the Best Oral Presentation Award at the 16th World Congress on Inflammation, showcasing his expertise in pro-resolving lipid mediators. ✈️ He was also awarded the Eicosanoid Research Foundation (ERF) Travel Award, enabling him to present groundbreaking research on lipid mediators and inflammation resolution at leading international conferences. 🔬 Beyond research, he serves as a peer reviewer for renowned journals, including Current Organic Chemistry, Current Materials Science, and Tetrahedron Letters, contributing to scientific advancement. His dedication to biomedical innovation, mentorship, and scholarly excellence has earned him global recognition. His commitment to advancing inflammation research through novel therapeutic strategies cements his reputation as a top-tier researcher and a deserving recipient of the Best Researcher Award.

Research Focus

Dr. Robert Nshimiyimana’s research focuses on the identification of bioactive chemical signals, pathways, and cellular targets responsible for stimulating the innate resolution of inflammation. His work integrates organic chemistry, biochemistry, and molecular biology to investigate how lipid mediators regulate immune responses and promote tissue healing. 🔍 Using advanced analytical techniques like mass spectrometry (MS) and nuclear magnetic resonance (NMR) spectroscopy, he studies the biosynthesis and function of pro-resolving mediators such as resolvins, maresins, and lipoxins. His research aims to develop therapeutic interventions targeting inflammatory diseases, including arthritis, pneumonia, and lung injury. 🌎 His innovative studies have profound clinical implications, potentially leading to new treatments for chronic inflammatory disorders. With a track record of high-impact publications and groundbreaking discoveries, Dr. Nshimiyimana is at the forefront of inflammation resolution research, making him an exceptional candidate for the Best Researcher Award.

Publication Top Notes

A new E-series resolvin: RvE4 stereochemistry and function in efferocytosis of inflammation-resolution

E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for …

Elovanoids counteract oligomeric β-amyloid-induced gene expression and protect photoreceptors

Human leukocytes selectively convert 4S,5S-epoxy-resolvin to resolvin D3, resolvin D4, and a cys-resolvin isomer

Stereospecific metabolism of R-and S-warfarin by human hepatic cytosolic reductases

Infectious neutrophil deployment is regulated by resolvin D4

ELV-N32 and RvD6 isomer decrease pro-inflammatory cytokines, senescence programming, ACE2 and SARS-CoV-2-spike protein RBD binding in injured cornea

Elucidating the structure and functions of Resolvin D6 isomers on nerve regeneration with a distinctive trigeminal transcriptome

Mohamed Hassan | Medicine and Health Sciences | Best Researcher Award

Posted on 15/03/202515/03/2025 by ScienceFather

Mohamed Hassan | Medicine and Health Sciences | Best Researcher Award

Assist. Prof. Dr Mohamed Hassan, Tulane University School of Medicine, United States

Assist. Prof. Dr. Mohamed Hassan is a distinguished researcher in molecular biology, tumor biology, and virology 🧬. His groundbreaking work focuses on tumor progression, cancer stem cell biology, and innovative therapeutic strategies 🎯. With an extensive portfolio of high-impact publications 📄 and supervised doctoral candidates 🎓, his research significantly contributes to understanding melanoma resistance, non-receptor tyrosine kinases, and immune checkpoint inhibitors 🏥. He has collaborated with leading international institutions, enriching the field with novel discoveries in oncology 🔬. His contributions extend beyond research, fostering the next generation of scientists and improving clinical oncology outcomes 🏥.

Publication Profile

Orcid

Education

Dr. Mohamed Hassan earned his Ph.D. in Molecular Biology 🏅 from the University Hospital of Düsseldorf, Germany (2001), where his research focused on the interference of the Hepatitis C Virus (HCV) core protein with intracellular signal transduction in liver cells 🦠. He holds an M.Sc. in Molecular Biology 📖 from the University of Düsseldorf (1996), with a thesis on identifying and characterizing differentially expressed cDNA libraries in Plasmodium malaria chabaudi immune mice 🧪. His academic journey began with a B.Sc. in Biological Sciences 🏫 from Zagazig University, Egypt, and the University of Düsseldorf (1983). His expertise in cancer biology, virology, and molecular research 📊 has established him as a leading researcher in the field.

Experience

Assist. Prof. Dr. Mohamed Hassan is a dedicated cancer researcher with extensive expertise in tumor progression, oncological drug resistance, and precision medicine 🔬💊. He is currently a Senior Postdoctoral Fellow at the Institut National de la Santé et de la Recherche Médicale, University of Strasbourg, France (2018-2025) 🏥. Previously, he served as a Research Assistant Professor at Tulane University School of Medicine, USA (2016-2018) 🎓, and a Postdoctoral Fellow at the University Hospital of Düsseldorf, Germany (2002-2004). His groundbreaking work focuses on identifying biomarkers and developing targeted therapies to enhance cancer treatment worldwide 🌍🧬.

Research Focus

Assist. Prof. Dr. Mohamed Hassan’s research focuses on tumor progression, cancer stem-like cells, and treatment resistance 🧬. His work delves into melanoma’s resistance to standard therapies 🎯, mechanisms of tumor progression and immune evasion 🏥, and targeting cancer stem-like cells to enhance treatment efficacy 💊. He investigates the role of non-receptor tyrosine kinases in oncogenesis 🔬 and explores immune checkpoint inhibitors and their associated cutaneous adverse effects ⚕️. Additionally, his discovery of antimicrobial peptides holds promise for clinical applications 🦠. His contributions drive novel therapeutic strategies, improving cancer treatment outcomes worldwide 🌍.

CD133-Dependent Activation of Phosphoinositide 3-Kinase /AKT/Mammalian Target of Rapamycin Signaling in Melanoma Progression and Drug Resistance

Mechanisms of Melanoma Progression and Treatment Resistance: Role of Cancer Stem-like Cells

Induction of Antimicrobial Protein S100A15 Expression by Oral Microbial Pathogens Is Toll-like Receptors-Dependent Activation of c-Jun-N-Terminal Kinase (JNK), p38, and NF-κB Pathways